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SUMMARY 
Background: Aqueous extracts of Tridax procumbens 
(TP) (Compositae) and Phyllanthus amarus (PA) 
(Euphorbiaceae) are used in traditional medicine in 
Ghana to treat malaria. Previous studies have 
demonstrated the anti-trypanosoma, anti-bacterial and 
anti-HIV effects of TP and PA.  
Objective: To assess the antiplasmodial activity of 
extracts of TP and PA.   
Method: Aqueous extracts of TP and PA were 
prepared. A portion of each was freeze-dried and the 
remaining extracted sequentially with ethyl acetate and 
chloroform. Ethanolic extracts were also prepared. The 
antiplasmodial activity of the extracts was assessed 
with the 3H-hypoxanthine assay using chloroquine-
resistant (Dd2) Plasmodium falciparum parasites. 
Chloroquine was used as the reference drug. The 
modified tetrazolium-based colorimetric assay was also 
used to evaluate the red blood cell (RBC)-
protective/antiplasmodial activities and cytotoxicities 
of the extracts.     
Results: Results showed that TP and PA have 
antiplasmodial activities. The aqueous and ethanolic 
extracts of PA were the most active, yielding EC50 
values of 34.9μg/ml and 31.2μg/ml, respectively in the 
tetrazolium-based assay. The TP and PA produced and 
IC50 values of 24.8μg/ml and 11.7μg/ml, respectively 
in the hypoxanthine assay. Protection of human RBCs 
against P. falciparum damage by the extracts highly 
correlated with their antiplasmodial activities. None of 
the extracts, within the concentration range (1.9-
500μg/ml) studied produced any overt toxicity to 
human RBCs.  
Conclusion: The results indicate that both PA and TP 
have activities against chloroquine-resistant P. 
falciparum (Dd2) parasites. The antiplasmodial 
principles extracted into water and ethanol but not 
chloroform or ethyl acetate. 
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INTRODUCTION 
Malaria continues to be the most important parasitic 
disease in the world. Each year, up to three million 
deaths due to malaria are recorded globally, with 
Africa bearing more than 90% of the burden.
1
 Almost 
3% and 10% of disability adjusted life years are due to 
malaria mortality globally and in Africa, respectively. 
In spite of various control strategies, malaria 
chemotherapy the world-over is confronted with the 
challenge of the emergence and spread of malaria 
parasites which are resistant to available drugs.
2
 This 
makes the search for new antimalarial drugs 
imperative.  
 
In Ghana, malaria is the leading cause of morbidity, 
accounting for about 37.5% of all outpatients (OPD) 
attendance in the year 2006.
3
 It is also the leading 
cause of mortality in children under five years. Reports 
on a prevalence survey to profile the severity and 
seasonality of malaria and anemia performed in the 
Kassena Nankana district in the Northern region of 
Ghana indicated that 22% (n=2286) of cases were due 
to infections in the low transmission period and 61% 
during the high transmission period.
4
 Important 
pathophysiological features of malaria include parasite-





Over the years, plants have been important sources of 
new drugs.
6
 Several herbal remedies continue to 
provide easily accessible alternatives to widely used 
antimalarials such as sulfadoxine-perimethamine (SP), 
chloroquine and mefloquine.
7
 Some of these plants 
may be sources of new antimalarial agents. In Ghana, 
medicinal plants used to treat malaria include Tridax 
procumbens (Compositae). (and Phyllanthus amarus 
(Euphorbiaceae, Schum. & Thonn.).  
 
 




Similarly the latter is commonly used in Southeastern 
Nigeria for the treatment of malaria-related symptons.
8
 
In vitro antiplasmodial activity of Phyllanthus amarus 
against chloroquine sensitive Plasmodium falciparum 
strain 3D7 has been reported.
8
 Results of a phase two 
clinical trial conducted on antiplasmodial herbal 
remedy, consisting of eight ingredients including 
Phyllanthus amarus and administered by Nigerian 
herbalists, confirmed the efficacy of the remedy.
9
 
Tridax procumbens has been reported to have activity 
against some forms of Trypanosoma cruzi and bacteria, 
whilst Phyllanthus amarus has been shown to inhibit 
the DNA polymerase of hepatitis B virus and reverse 
transcriptase of HIV.
10,11,12
 However, these plants have 
not been investigated to establish their antimalarial 
properties particularly against drug-resistant parasite 
strains.  
 
Various methods including P. falciparum culture using 
3H-hypoxanthine uptake, have been employed in 
screening for new antimalarial drugs.
13
 Other methods 
like the tetrazolium assays which involve 
mitochondrial dehydrogenases and other dehydro- 
genases converting tetrazolium to formazan that 
indicates cell viability have been used to evaluate anti-
microbial agents.
14,15
 The assay has also been used in 
models for screening cytocidal chemical agents.
16,17
 In 
this paper, we report the in vitro RBC protecting and 
antiplasmodial activities of Tridax procumbens and 
Phyllanthus amarus. 
 
MATERIALS AND METHODS 
Parasite culture 
Chloroquine-resistant strain of P. falciparum, Dd2, 
(Centre for Medical Parasitology, Copenhagen, 
Denmark) was maintained in continuous culture by the 
modified method of Jensen and Trager
18
 using RPMI 
1640 medium containing Hepes, and NaHCO3 but 
without glutamine (Sigma Chemical Co. St. Louis, 
MO, USA). The medium was supplemented with 10% 
normal human serum (NHS), 1mg/ml L-Glutamine, 
1mg/ml of D-Glucose (Sigma Chemical Co. St. Louis, 
MO, USA), and 80μg/ml of gentamicin (Gibco BRL 
Life Technologies, Paisley, Scotland). After informed 
consent, volunteers with blood group O Rh+ donated 
whole blood for the study. All other chemicals were of 
analytical grade and obtained from Sigma Chemical 
Co. St. Louis, MO, USA and Gibco BRL Life 
Technologies, Paisley, Scotland. 
 
The proposal was reviewed and cleared by the 
appropriate institutional board of the Noguchi 
Memorial Institute for Medical Research (NMIMR), 




Phyllanthus amarus (PA) and Tridax procumbens (TP) 
were supplied by Papa Issah Yemoh, a Ghanaian 
traditional medicine practitioner. Phyllanthus amarus 
(voucher #GC47813) and Tridax procumbens (voucher 
#GC47814) were authenticated at the Ghana 
Herbarium, Department of Botany, University of 
Ghana, Legon, where voucher specimens have been 
deposited. Phyllanthus amarus belongs to the family 
Euphorbiaceae. The plant grows up to no more than 1½ 
feet tall and has small yellow flowers, small leaves, 
very small (2mm) fruits that burst open causing the 
seeds to be hurled way. Tridax procumbens, on the 
other hand belongs to the family Compositae. It is a 
very hairy plant with coarsely toothed leaves. It has six 
ray yellow composite flowers. 
 
Extraction 
The whole plant of Phyllanthus amarus and the stem, 
flowers and leaves of Tridax procumbens were picked 
air-dried and prepared as follows: 4g of each plant 
were boiled separately in 100ml of water for 5min. A 
portion of each of the aqueous extracts was freeze-
dried and refrigerated for later use. The remaining 
aqueous extract was sequentially extracted with cold 
chloroform and ethyl acetate. A fresh sample of each 
plant was also extracted with ethanolic (cold 
maceration). Each of the organic extracts or fraction 
was evaporated under vacuum. 
 
In vitro antiplasmodial assays 
Inhibition of 3H-hypoxanthine uptake 
The antiplasmodial activities of the plant extracts were 
determined with the inhibition of 3H-hypoxanthine 
uptake assay as described by Desjardins et al.
 13
 
Parasitized RBCs (5 X 10
8
 cells/ml) at a parasitemia of 
1.5% were added to wells of a 96-well microtitre plate, 
containing the test extracts or chloroquine at 
concentrations ranging between 1.9 - 500μg/ml and 0.1 
- 100µg/ml, respectively. Parasite and RBC controls of 
infected and uninfected RBCs, respectively, were 
placed in wells with culture medium without plant 
extracts. The plates were incubated at 37
o
C in a 
humidified incubator at 5% of O2 and CO2 for 24h. 
This was followed by the addition of 20μl of 3H-
hypoxanthine (40μCi/ ml) to each well and the plates 
incubated further for 24h.   
 
Each plate was then kept in a refrigerator (4
o
C) to stop 
the reaction and store the cultures prior to cell 
harvesting. Cells were harvested unto glass fibre filters 
(Filter Mate 96 Cell Harvester, Model A960961, 








The filters were dried in an incubator at 37
o
C for 24h 
after which radioactivity was counted (Direct Beta 
Counter matrix 96, Model A960961, Packard A 
Canberra company, USA), to determine the 
incorporation of radio-labelled hypoxanthine. 
 
Tetrazolium based colorimetric (MTT) assay 
A modified version of the tetrazolium based 
colorimetric assay was used to screen the plant extracts 
for their antiplasmodial activity and toxicity to RBCs.
14
 
In this assay 100μl of each of the crude extract 
(concentration range 1.9 - 500μg/ml) was placed in 
separate wells of a 96-well microtitre plate in duplicate. 
This was followed by the addition of 100μl of 
Plasmodium falciparum infected RBCs (2.3 x 108 
cells/ml) at a parasitemia of 1.5% to each well. The 
contributions of plant extracts, culture medium, 
infected and uninfected RBCs to the optical densities 
were excluded by setting up control experiments for 
each of these parameters separately alongside the main 
experiments.  
 
All plates were incubated at 37
o
C for 5 days in a 
humidified incubator at 5% O2 and CO2 after which 
20μl of MTT (7.5 mg/ml) were added to each well and 
the plates incubated again for 2h. Aliquots of culture 
media (150μl) were removed from each well and 
discarded. Triton X-100 in acidified isopropanol 
(200μl) was added to each well to dissolve any 
formazan formed. The plates were then kept at room 
temperature in the dark for 24h and the optical 
densities (OD) of the wells were read at 565 and 
690nm on an ELISA plate reader (Molecular Devices 
Corporation, Menlo Park, California). The percent cell 
protection and survivals were computed using the 
modified formula of Ayisi et al (1991). These values 
were plotted against concentrations of extracts, and the 
50% cell protection (effective concentration, EC50) 
and survival (cytotoxic concentration, CC50) were 
determined. The selective indices of the extracts were 
also computed as the ratio of the CC50 to the EC50. 
 
RESULTS  
The results for the extract-mediated RBC protection 
and the antiplasmodial activities of the plant extracts 
are shown in Figures 1 and 2. Figure 1(1) shows that 
the aqueous extracts of PA protected the RBCs in a 
concentration-dependent fashion, starting at a 
concentration well below 100μg/ml. RBC protection by 
aqueous TP started at a concentration of 100μg/ml. 
Unlike the aqueous extracts, the ethanolic extracts of 
both PA and TP showed significant concentration-
dependent cell protection (Figure 1(2)) but decreased 
sharply at a TP concentration of 100μg/ml and above. 
Neither the chloroform nor the ethyl acetate fractions 
of TP offered any significant cell protection (Figures 
1(3) and 1(4)). However, the corresponding extracts of 
PA showed a considerable RBC protection at 
concentrations higher than 100μg/ml. Similar results 
were obtained when the antiplasmodial activity of the 
extracts were assessed with the inhibition of 3H-











        SI
3
 
Extracts PA TP PA TP PA TP 
Aqueous 34.9 >500 >500 >500 nd nd 
Ethanol 31.2 121.3 >500 >500 nd nd 
Chloroform 263.9 >500 302.6 >500 1.1 nd 
Ethyl acetate 368.4 >500 389.7 >500 1.1 nd 
 
1 50% Antiplasmodial effective concentration. 
2 50% Cytotoxic concentration. 
3 Selective index. The SI was calculated as the ratio of CC50 to EC50 
Data represents means for duplicate experiments. 
nd: not determined as a result of determinants being out of range. 
 
The results presented in Figure 3 indicate that survival 
of RBC exceeded 70% for all extracts over the concen-
tration range (1.9-500 μg/ml) studied. At concentra-
tions below 62.5μg/ml the aqueous extract of TP ap-
peared to be relatively less toxic to the RBCs than that 
of PA (Figure 3(1)) whereas for the ethanolic extracts 
of PA appeared to be less (Figure 3(2)). Although the 
chloroform extracts of TP and PA also showed low 
toxicities to RBCs the toxicity of PA to the RBCs in-
 
 




creased sharply at concentrations higher than 125μg/ml 
(Figures 2(3-4)). 
 
The effective median concentrations for RBC 
protection (EC50) and RBC survival (cytotoxic 
concentration- CC50) determined from Figures 1 and 3 
are shown in Table 1. The table shows that the aqueous 
and ethanolic extracts of PA yielded the lowest EC50. 
For TP, apart from the ethanolic extract that produced 
an EC50 of 121.3μg/ml, the EC50 for all the other 
fractions were higher than the highest concentration 
(500μg/ml) used in these studies. The CC50 values also 
could not be determined for the TP extracts because the 
percent cell survival values at all concentrations 
studied were greater than 50% (Figure. 2).  
 
Fig. 3  Concentration-dependent effect of aqueous extracts
of T610 and S076 on RBC protection
Log concentration (g/ml)






























Fig. 4  Concentration-dependent effect of aqueous extracts
of T610 and S076 on RBC survival 
Log concentration (g/ml)






























Fig. 5  Concentration-dependent effect of ethanolic extracts
 of T610 and S076 on RBC protection
Log concentration (g/ml)




























Fig. 6  Concentration-dependent effect of ethanolic extracts
of T610 and S076 on RBC survival
Log concentration (g/ml)



























 Fig. 7  Concentration-dependent effect of chlorofom extracts
of T610 and S076 on RBC protection
Log concentration (g/ml)





























Fig. 8  Concentration-dependent effect of chloroform extracts
of T610 and S076 on RBC survival  
Log concentration (g/ml)



























Fig. 9  Concentration-dependent effect of ethyl acetate extracts
of T610 and S076 on RBC protection
Log concentration (g/ml)





























Fig. 10  Concentration-dependent effect of ethyl acetate extracts
of T610 and S076 on RBC survival
Log concentration (g/ml)




























Figure 1 Plots showing protection of RBCs by aqueous (1), ethanolic (2), chloroform (3) and ethyl acetate (4) ex-
tracts of TP and PA. Incubations were carried out using microtitre plates as described previously.
14
 Experimental 
well contained 2.3 x 10
7
 of chloroquine-resistant P. falciparum infected RBCs at a parasitemia of 1.5%. Parasite 













H-HPO) uptake in 
P. falciparum (strain Dd2) by aqueous extracts of T610 and S076
Log concentration (g/ml)




































H-HPO) uptake in 
P. falciparum (strain Dd2) by ethanolic extracts of T610 and S076
Log concentration (g/ml)






























    




H-HPO) uptake in 
P. falciparum (strain Dd2) by chloroform extracts of T610 and S076
Log concentration (g/ml)


































H-HPO) uptake in 
P. falciparum (strain Dd2) by ethyl acetate extracts of T610 and S076
Log concentration (g/ml)





































H-HPO) uptake by P. falciparum (strain Dd2) by aqueous 
(1), ethanolic (2), chloroform (3) and ethyl acetate (4) extracts of TP and PA. Incubations were performed as de-
scribed by Desjardins et al
13
 with each well containing 2.3 x 10
7
 of chloroquine-resistant P. falciparum infected 
RBCs at a parasitemia of 1.5%. Parasite infected RBCs were treated with different concentrations of the plant ex-
tracts ranging from 1.9 to 500μg/ml. 
 
Similar results were obtained for the aqueous and 
ethanolic extracts of PA. The CC50 of the chloroform 
and ethyl acetate extracts of PA were below 500μg/ml 
thus enabling a computation of their selective indices 
(CC50/EC50). The median inhibitory concentrations 
(IC50) of the aqueous, ethanol, chloroform and ethyl 
acetate extracts of PA determined with chloroquine-
resistant P.falciparum strain (Dd2) in the 3H-
hypoxanthine uptake assay were 24.8μg/ml, 11.7μg/ml, 
173.6μg/ml and >500 μg/ml, respectively. For TP, the 
IC50 values were 225.0μg/ml, 143.4μg/ml, 430.6μg/ml 
and 250.0μg/ml, respectively for the aqueous, ethanol, 
chloroform and ethyl acetate extracts. The reference 
drug, chloroquine, demonstrated a concentration-
dependent inhibition of parasite growth within the 












Fig. 3  Concentration-dependent effect of aqueous extracts
of T610 and S076 on RBC protection
Log concentration (g/ml)




























































Fig. 5  Concentration-dependent effect of ethanolic extracts
 of T610 and S076 on RBC protection
Log concentration (g/ml)
























































Fig. 7  Concentration-dependent effect of chlorofom extracts
of T610 and S076 on RBC protection
Log concentration (g/ml)

























































Fig. 9  Concentration-dependent effect of ethyl acetate extracts
of T610 and S076 on RBC protection
Log concentration (g/ml)


























































Figure 3 Plots showing RBCs survival in incubations containing aqueous (1), ethanolic (2), chloroform (3) and 
ethyl acetate (4) extracts of TP and PA. Incubations were carried out using microtitre plates as described previ-
ously.14 Each experimental well contained 2.3 x 107 of non-infected human RBCs. RBCs were treated with differ-
ent concentrations of the plant extracts ranging from 1.9 to 500μg/ml.  
 
DISCUSSION 
Traditional healers in Ghana use Phyllanthus amarus 
(PA) and Tridax procumbens (TP) separately to 
manage various diseases including malaria. The present 
study shows that each of the plants has anti-plasmodial 
activities. Results from the tetrazolium-based 
colorimetric assay
14
 offered an added advantage in 
showing that the plants also protected RBCs against P. 
falciparum mediated damage. This is significant 
because RBC damage and hence loss are important 
pathophysiological features that precipitate the serious 
complications of anaemia associated with malaria 
infections.
5
 The viability of the RBCs in this study was 
confirmed by their ability to convert tetrazolium to 
formazan. The standard and direct method of 
Desjardins et al
13
, uses the inhibition of 
3
H-










 Our results, therefore, show that in addition, to their 
RBC protective effects, the aqueous and ethanolic 
extracts of PA and TP inhibited growth of the 
chloroquine-resistant P. falciparum parasites used in 
the cultures. Ethyl acetate and chloroform extracts at 
high concentrations seemed to have adverse effects on 
the RBCs, demonstrated by a sharp drop in cell 
survival. The comparatively lower EC50 and IC50 values 
obtained for the ethanolic and aqueous extracts indicate 
that these solvents extracted more of the antiplasmodial 
agent. An in vivo study on antiplasmodial effect of 
aqueous extract of PA showed that it inhibits 
Plasmodium berghei growth in mice.
20
 Other studies 
have also reported in vitro antiplasmodial activity of 
aqueous and ethanolic extracts of PA.
,20,21
 These results 
and those of others showing that these plants have anti-
microbial activities
10,11,12 
are consistent with claims of 
traditional medical practitioners that TP and PA are 
effective remedies.  
 
In general, neither TP nor PA was overtly toxic to 
human RBCs in culture. As a result of their low 
toxicity to RBCs, the median cytotoxic concentration 
(CC50) could not be determined for most of the 
extracts. At higher extract concentrations of ethyl 
acetate and chloroform, however, PA appeared to 
affect the RBCs adversely (Figure 3(3 and 4)). Reports 
on toxicity studies on aqueous extract of PA on rats 
however revealed potential toxic effects of the 
extract.
22
 Thus, further investigations are required to 
establish the safety of PA in humans. At concentrations 
below 31μg/ml PA appears to exhibit stimulatory 
effects on the cells resulting in the observed high RBC 
survival (Figure. 3(2)). It is significant to note that the 
IC50 of 40 μg/ml for chloroquine (the standard drug) 
reported here, is far higher than the 1-64pmol/well 
reported for micro-tests.
19
 This affirms that the P. 
falciparum parasite (Dd2) strain used for the 
experiments described here are indeed chloroquine-
resistant. Therefore, the aqueous and ethanolic extracts 
of PA and TP are effective against the chloroquine-
resistant P. falciparum parasites. 
 
CONCLUSION 
We conclude from our results that the aqueous and 
ethanolic extracts of PA and TP have antiplasmodial 
activity against chloroquine-resistant P. falciparum 
parasites. The extracts have considerably low toxicities 
to human RBCs. These results lend support to claims 
of herbalists that decoctions of either TP or PA are 
useful medicines. These notwithstanding, more 
comprehensive animal toxicity studies need to be 
carried out on the plants, especially since humans are 
currently using them to treat malaria and other 
diseases.  
This could be followed by pilot clinical trials for 
therapeutic dose range finding as well as proper 
documentation of effects of these plant medicines on 
humans. Evaluation of the antiplasmodial activities of 
the extracts in vivo would be helpful in assess the 
effects of the extracts in vivo. The plant extracts of TP 
and PA could be useful alternatives to antimalarial 
drug or useful in combination therapy, since they are 
much cheaper. This report demonstrates that the MTT 
assay which is relatively cheaper compared to the 
radiolabeled hypoxanthine assay will be a very useful 
assay system for screening for antimalarial agents. 
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